Facts About Fibroid Treatment
Fibroid treatment varies depending on the location of the fibroids and their symptoms. Treatment options include surgery, medications, and lifestyle changes. Access Vascular Health: Michelle Maneevese, MD has some nice tips on this. Fibroids are benign growths inside the uterus that can cause pain during your period. About two out of three women will develop them by the time they reach the age of 50. Women suffering from uterine fibroids should consult with a doctor to decide the best treatment option for their specific situation.
Surgical treatments for fibroids include hysterectomy and myomectomy. Hysterectomy removes the fibroids while preserving the uterus, which may help preserve a woman’s fertility. However, there are risks involved with this surgery. Patients should consider their age, whether they plan to have children, and the severity of the fibroid.
Fibroids can be painful, but there is a non-surgical treatment for fibroids that will relieve the pain. This procedure may not be suitable for women with uterine fibroid symptoms or who are suffering from other medical conditions. Women with fibroids should be aware of the risks involved before undergoing surgery.
A minimally invasive procedure called uterine artery embolization may be an option for women with symptoms of fibroid pain. Fibroid-reducing agents are injected through a catheter guided by fluoroscopy. As a result, the fibroids will begin to shrink and die. As fibroids shrink, the uterus can recover and regain its normal function.
Another treatment for fibroids is a hormonal treatment called mifepristone. This is a 19-norsteroid synthetic hormone (SPR) that inhibits the growth of uterine fibroids. In a recent study, mifepristone was found to significantly reduce the size of fibroids and reduce menstrual pain. It is also an effective treatment for heavy menstrual bleeding.
This procedure has been shown to have a high NPV (number of fibroids treated) and is effective for patients with severe fibroids. However, some patients may not respond to the procedure or experience a relapse of symptoms. Therefore, patients should check with their insurance company before undergoing treatment.
The ExAblate 2000 System is an FDA-approved focused ultrasound system. It is currently available to women with symptomatic uterine fibroids. In a pivotal trial of 192 patients in the U.S., ExAblate achieved a measurable reduction in symptoms and volume in 70.6 percent of women. The average follow-up period was 2.8 years.
Despite the benefits of MRgFUS, the procedure is not always as effective as surgery for women with fibroid. Further tests are needed to validate the effectiveness of this treatment. A recent study published in the Journal of Surgery for Fibroids found that women who received MRgFUS treatment had a significantly lower rate of fibroid symptomatic symptoms.
During the MRgFUS procedure, patients will need to change into a gown and lie on the treatment table. The radiologist will monitor their progress and review the temperature-sensitive images during the procedure. The procedure usually takes a few hours and depends on the size and number of fibroids in a woman’s body. Patients will be given light sedation and will probably need someone to drive them home after the procedure.
Contact Info
Access Vascular Health: Michelle Maneevese, MD
5151 Katy Freeway Suite 170 Houston, TX 77007
Phone No. : 832-981-5781
